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1. Introduction
  Since ancient times, Ocimum sanctum(O. sanctum), a 
well known medicinal plant of the Indian subcontinent has 
been revered and used in Ayurvedic system of medicine. 
Most of the research done on O. sanctum, confirmed dozens 
of its traditionally known action and therapeutic uses 
including its remarkable adaptogenic[1,2] and anti stress 
activity[3-6]  as well as its powerful support for the immune 
system[7-9]. About the immunity, it is well documented that 
it increases the cell mediated and humoral immunity of 
the body[10-15]. Now it is well known that herbal medicines 
act as immunomodulator through the dynamic regulation 
of information molecules such as cytokines. This may offer 
an explanation for the effect of this herb on the immune 
system[16]. But there is little information or documentation 
regarding the cytokines induction by O. sanctum[17]. 
Our previous studies demonstrated that aqueous O. 
sanctum extract enhanced the synthesis of IFN-毭 by rat 
splenocytes in vivo as well as in vitro studies. Extract was 
also found as splenocytes proliferative factor[18]. 
  In view of the effect of leaves extract on the enhancement 
of IFN-毭 production and splenocytes proliferation, this 
study focused on the possible effect of O. sanctum on IL-2 
production. IL-2 is the principal cytokine produced by 
native helper T-cells[19, 20]. T-helper cells are divided into 
Th1 and Th2 cells from the profile of cytokine secretion[21]. 
It is also known that Th1 cells are able to produce IL-2 
& IFN-毭 and Th2 cells can produce IL-4 and IL-10 
cytokines[22]. IL-2 acts as a growth factor for both Th1 and 
Th2 lymphocytes[23] and plays a direct role in the induction 
of B lymphocytes[24].
  In the present work we studied the effect of O. sanctum 
leaves aqueous extract on IL-2 cytokine production by 
spleen cells and on routine blood parameters and T& B 
lymphocytes in peripheral blood, which are responsible for 
the overall increase in cell mediated & humoral immunity. 
Sandwich enzyme-linked immunosorbent assay (ELISA) 
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IL-2. Investigation in vitro also showed regulation of IL-2 production. Blood study exhibited 
leucocytosis and augmentation of T& B lymphocytes by 25% approximately. 4-5% increase in 
Hemoglobin value was also noticed.  Conclusion: Aqueous Ocimum sanctum leaves extract may 
have stimulatory effect on T & B lymphocytes particularly on Th1 subset of lymphocytes as shown 
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and m-RNA expression for IL-2 production by RT-PCR 
analysis were performed.
2. Materials and methods
2.1. Chemicals & reagents
  RPMI-1640 medium, fetal bovine serum, Concanavalin-A 
(ConA), 3-(4,5-dimethylthizol-2-yl)-2, 5-diphenyl 
tetrazolium bromide (MTT), TRI reagent and histopaque-
1077 were purchased from SIGMA, USA. RT-PCR kit & 
penicillin-streptomycin were from Bangaloregenei, India. 
Rat IL-2 ELISA kit was obtained from R&D System, USA. 
Primers used were from Bioserve, India. Nylon wool was 
purchased from Polysciences. Inc, USA.
2.2. Preparation of herbal drug extract 
  Leaves of O. sanctum were collected from the garden of 
College of Veterinary Sciences, DUVASU, Mathura. The 
leaves and seeds were authenticated from the National 
Botanical Research Institute, Lucknow. Leaves were dried 
in shade and pulverized. 100 mg powder was extracted with 
500 mL Triple distilled water (TDW) at room temperature 
for 3 days with a few drops of chloroform to avoid fungal 
growth. The extract was filtered, lyophilized and stored.
2.3. Animals 
  Wistar rats (100-120 mg), purchased from IVRI, Bareilly, 
India were kept at (24依2) ℃. Food and water were available 
ad libitum. The care of the animals was in accordance to 
the Guidelines for the care and use of Animals in Scientific 
Research, prepared by Indian National Science Academy, 
New Delhi[25]. The rats were randomly divided into two 
groups with 10 rats in each group. O. sanctum aqueous 
leaves extract which was found to be non-toxic and effective 
stimulator of haemopoetic system in preliminary studies was 
administrated (P.O.) at dose of 250 mg/kg by blunt 20 gauge 
needle syringe once a day in a volume of 100 滋L for 20 days 
in experimental group; while in control group equal volume 
of water (placebo) was given. The experimental protocol was 
approved by the Institutional Animal Ethics Committee.
2.4. Effect on IL-2 production
2.4.1. Preparation of splenocytes
  Spleen cell suspensions from each animal group were 
prepared as advocated by Xie et al[26] in RPMI-1640 
medium and depleted of red blood cells by incubating it 
with 0.15 M ammonium chloride in 0.01 M tris buffer for 
15 mins. Cells were washed twice in RPMI-1640 medium 
by centrifugation at 1 200 rpm for 10 mins. The pallet 
thus obtained was resuspended in RPMI-1640 medium 
supplemented with 2 mM L-glutamine, 100 units/mL 
of penicillin, 100 滋g/mL streptomycin, 5×10-5 M 毬 
mercaptoethanol, 25 mM NaHCO3 and 10% fetal bovine 
serum. Viable spleen cells were counted in hemocytometer 
by trypan blue exclusion. Triplicate cultures were performed 
in 96 wells flat bottomed tissue culture plates in a final 
volume of 200 滋L/well containing 4伊105 cells. ConA 
was added at 5 滋g/mL.  In study in vitro, plant extract at 
different concentrations (25-500 滋g/mL) were added into 
splenocytes of control animals in the presence of ConA. 
Then the cells were incubated for 48 hrs at 37 ℃, 5% 
CO2. Cell culture supernatants were removed and stored at 
-70℃ for IL-2 cytokine assay.
2.4.2. IL-2 assay
  Il-2 cytokine was quantitated by sandwich ELISA as per 
protocol of R & D Systems, USA. In brief, ELISA plates 
were coated with goat anti rat IL-2 antibodies overnight 
at 4 ℃. Additional binding sites were blocked with 1% 
BSA in PBS. Both standard cytokine and samples (culture 
supernatants) were added into the ELISA plate. The plate 
was incubated for 2 hrs at room temperature and washed. 
Afterwards, biotinylated goat anti rat IL-2 was added, 
the plate was incubated for another 2 hrs and washed. 
Strepavidin-HRP conjugate was further added for 20 
mins sin dark and washed. Finally the substrate, TMB was 
added for 20 mins in dark. The reaction was stopped by 2N 
H2SO4 and optical density of each well was determined at 
dual wavelength 450 nm-570 nm by an ELISA reader. The 
concentrations of IL-2 in the samples were determined with 
the help of standard curve of IL-2.
2.5. Effect on IL-2 gene expression
  The level of IL-2 mRNA in the spleen cells was estimated 
using RT-PCR analysis after 24 hrs culture in the presence 
of 5 滋g/mL ConA.
2.5.1. Extraction of total RNA
  107 spleen cells from control and O. sanctum treated 
animals after 24 hrs cultures were lysed with 1 mL TRI 
reagent and the mixture was forced to pass through pipettes 
to release RNA from the cells. The homogenate was then 
vigorously mixed with 0.2 mL chloroform. After sitting at 
room temperature for 15 mins, the mixture was spun at 
12 000 g for 15 mins at 4 ℃ to separate the aqueous phase 
from organic phase. The aqueous phase was transferred 
into a new tube and RNA was precipated with 0.5 mL of 
isopropanol and centrifuged at 12 000 g for 10 mins at 
4 ℃. The RNA pellet was washed by 75% ethanol and 
finally suspended in 20 滋L of RNAse free water.
2.5.2. cDNA synthesis
  cDNA was synthesized according to the protocol of RT-PCR 
kit. 5 滋L volume of total RNA was added into 10 滋L RNAse 
free water and then mixed with 0.2 滋g of oligo (dt)18 primer 
in 1 滋L . The mixture was heated at 65 ℃ for 10 mins, 
followed by 2 mins cooling at room temperature and then 
placed on ice. A reaction mixture containing 4 dNTPs, DTT, 
RT buffer, RNAsin and M-MuLV reverse transcriptase was 
subsequently mixed with RNA. The reaction was carried out 
at 37 ℃ for 1 hr to synthesize the cDNA and then incubated 
at 95 ℃ for 2 mins to denature the RNA-cDNA hybrids and 
quickly placed on ice.
2.5.3. PCR
  3 滋L cDNA was mixed with PCR buffer, 4 dNTPs, Taq 
DNA polymerase and 100 滋g of each forward and reverse 
primer. The sequences of primers advocated by Asa 
Melhus[27] were as following:
  Il-2: 5'-AGC TGT TGC TGG ACT TAC AGG-3', 5'-AAT 
TCC ACC ACA GTT GCT GG-3';
  毬- actin: 5'- TGG AGA AGA GCT ATG AGC TGC-3', 
5'-TCC ACA CAG AGT ACT TGC GC-3'. 
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  毬-actin was taken as internal control. The PCR 
conditions were denaturated at 94 ℃ for 1 min, annealed 
at 55 ℃ for 1 min and extended at 72 ℃ for 2 mins. After 
35 cycles of amplification, the final extension was done at 
72 ℃ for 10 mins. The PCR products were subjected to 
gel electrophoresis on 1.5% agarose containing ethidium 
bromide. The amplicions were compared with a DNA 
molecular size marker (100 bp ladder) under UV light. The 
images were analyzed densitometrically. For each cDNA 
sample, the densitometric units of the amplified c-DNA 
fragments were counted for semi quantitative evaluation.
2.6. Effect on hematological parameters
  Blood was collected from the orbital plexes and various 
parameters including total leukocyte count (heamocytometer), 
differential count (leishman's stain) and hemoglobin level 
were recorded by conventional procedures.san extension 
of TYPHIdotTM which already well evaluated[5, 6]. These 
methods were based on the recombinant protein produced 
from the gene sequence of the 50 kD OMP.
2.7. Effect on T & B lymphocytes
  3 mL of blood was also taken from each animal of both 
groups and after layering the blood over histopaque 1077 
(sigma), total lymphocytes were separated and counted. T 
and B lymphocytes were separated on sterilized nylon wool 
columns (Poly sciences Inc, Washington) made in 10 mL 
syringe according to their protocol. After incubating the 
lymphocytes on nylon wool columns for one hour at 37 ℃, 
nonadherent T-cells were collected in RPMI-1640 while 
the plastic adherent B-cell were eluted by pressing the 
column with piston (2-3 times). The T and B-cell were 
separately counted by heamocytometer.
2.8.  Statistical analysis
  All values were expressed as mean依standard error of mean 
(SEM). Analysis was done using graph pad prism version 5.0. 
The parameters were evaluated with paired t-test. A P-value 
of 0.05 or less was taken as statistically significant.
3. Results
3.1. Effect on IL-2 production  
  
  Both studies in vivo and in vitro showed that O. sanctum 
extract enhanced the production of IL-2. Test in vivo showed 
concentration of IL-2 in control group was (569.22依120.97) pg/
mL without any change, while the concentration in O. sanctum 
treated group was (667.71依137.50) pg/mL with change percentage 
as 17.3%. The O. sanctum extract appeared significant effect 
(P<0.001). The IL-2 production was also increased significantly 
with O. sanctum concentrations at 100 滋g/mL, 250 滋g/mL & 
500 滋g/mL (P<0.001, Table 1), and the increase was dose-
dependent.
3.2. Effect on IL -2 gene expression
  IL-2 production was also measured by IL-2 m-RNA 
expression. RT-PCR analysis of IL-2 m-RNA expression 
showed that the length of IL-2 and 毬-actin were 307 and 315, 
respectively. The raw volume of peak of IL-2 and 毬-actin were 
44 662.44 and 134 234.42, respectively in control group without 
any significant change; while the raw volume of peak of IL-2 and 
毬-actin were 103 883.91 and 137 091.44, respectively, with 
change percentage as 132.6% and 127%, respectively in treat 
group  (Figure1).
Table1 
In vitro effect of O. sanctum aqueous leaves extract  on IL-2 
production from splenocytes.
Groups Concentration of IL-2 
 (pg/mL, mean依SEM)
change in IL-2 
concentration(%)
ConA control  569.22依120.97 --
ConA+ O.sanctum
 (25 滋g/mL)
572.93依122.01 0.65
ConA+ O.sanctum
(50 滋g/mL)
588.64依126.53* 3.41*
ConA+ O.sanctum
(125 滋g/mL)
619.42依129.56** 8.8**
ConA+ O.sanctum
(250 滋g/mL)
655.25依135.54** 15.1**
ConA+ O.sanctum
(500 滋g/mL)
632.78依132.04** 11.2**
 * P<0.05, **P<0.01.
  Lane1: IL-2 (control); Lane2: IL-2 (O. sanctum); Lane3:毬-actin 
(control); Lane4:毬 -actin (O. sanctum); Lane5: 100 bp ladder.
Figure 1. m-RNA expression of IL-2 cytokine& 毬-actin (control 
protein) in control and O. sanctum treated rats' splenocytes by RT-
PCR.
3.3. Effects on hematological parameters
  Pretreatment for 21 days with O. sanctum extract 
produced a striking leukocytosis ( Figure 2) with a marked 
lymphocytosis (Figure 3). Elevated level of Hb was also 
recorded in O.sanctum fed animals (Figure 4).
3.4. Effect on T & B lymphocytes
  The O. sanctum leaves produced a stimulatory effect 
on T-B lymphocytes as augmentation indication of in the 
number of total lymphocytes, T as well as B lymphocytes 
(Figure 5).
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4. Discussion
  Our observation in this study demonstrated that O.sanctum 
leaves have immunomodulating effect by stimulating IL-2 
Figure 2. Effect of O. sanctum aqueous leaves extract on total 
leukocyte count in blood.
Figure 3. Effect of O. sanctum aqueous leaves extract on lymphocytes 
& Neutrophils percentage in DLC of blood.
Figure 4.  Effect of O. sanctum aqueous leaves extract on hemoglobin 
concentration in blood.
Figure 5.  Effect of O. sanctum aqueous leaves extract on total 
lymphocytes and T&B lymphocytes concentrations in blood.
cytokine production. Both secretion and m-RNA expression 
of IL-2 were increased in the spleen cells taken from O. 
sanctum leaves extract fed rats.  Experiments in vitro also 
exhibited increase in IL-2 synthesis. IL-2 is a well known 
cytokine that is produced by naive CD4+ T cells and under 
the influence of IL-2 secretion CD+ T cells get differentiated 
into Th1 cells[24, 28].
  Moreover, our previous study also indicated that O. 
sanctum leaves extract modulate IFN-毭 production[18]. 
IFN-毭 is a defining cytokine of the subset Th1. Thus it 
may be possible that leaves extract may also have potential 
to stimulate Th1 which in turn produce IL-2 and IFN-
毭 cytokines that promote differentiation of fully cytotoxic 
TC cells from CD8+ precursor. IL-2 stimulates the growth, 
differentiation and survival of antigen selected cytotoxic 
T-cells via the activation and expression of specific gene[29-
30]. This pattern of cytokine induction makes the Th1 
subset essentially suit to viral infection and intracellular 
pathogenesis. Recently, ultra low dose of IL-2 therapy in 
patients with AIDS, promotes Th-1 cytokine profile i.e. 
IFN-毭 and enhances immune functions[31-32]. Higher cost 
and the administration of IL-2 may have intense adverse 
localized effect. While augmentation of IL-2 level by O. 
sanctum leaves extract as seen in this study may exclude 
above stated side effects. Thus it can be beneficially used as 
an alternative medicine approaches in immune suppressed 
conditions like AIDS without any toxic effects. 
  Our study also demonstrated that the O. sanctum improves 
overall body constitution by increasing Hb, leukocytosis 
and lymphocytosis. Several researches have confirmed 
repeatedly that O. sanctum increases both specific and 
nonspecific immunity[10,11,12,33]. Thus a rise in white blood 
cell count with significant increase in lymphocyte count 
accounts for its immunostimulating activity. 
  In our study we used crude extract which may be proved 
more potent and effective than any single purified compound 
because ingredients/components present in crude extract 
may show synergistic activity. Many works reported that the 
use of whole plants, instead of isolated chemicals may offer 
a safer clinical strategy in the treatment of many diseases[34-
36]. 
  It is concluded that at the present time when we are 
facing with the limitations of modern medical science in 
responding to the diseases, phototherapy appears to be a 
potential part of the solution. The researches in vivo and in 
vitro demonstrated that O. sanctum modulate the secretion 
of cytokines and show promising therapeutic value. Such 
scientific validation will facilitate the medicinal efficacy of 
Indian herbal medicinal system. 
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